PNT — POINT Biopharma Global Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid Cap

Annual balance sheet for POINT Biopharma Global, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K
Standards:	USG	USG	USG	USG
Status:	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	0	10.5	239	525
Net Total Receivables	—	0.059	0.073	0.06
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.001	12.4	244	531
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0	9.8	19.4	31.4
Long Term Investments
Total Assets	0.001	22.2	263	578
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.01	5.16	7.98	79.7
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	0.01	8.71	8.05	91.4
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-0.009	13.5	255	487
Total Liabilities & Shareholders' Equity	0.001	22.2	263	578
Total Common Shares Outstanding